Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Change in Inventory (2016 - 2019)

Plus Therapeutics (PSTV) has disclosed Change in Inventory for 10 consecutive years, with $15000.0 as the latest value for Q4 2019.

  • Quarterly Change in Inventory fell 89.29% to $15000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was -$24000.0 through Jun 2020, up 92.92% year-over-year, with the annual reading at -$259000.0 for FY2019, 45.47% up from the prior year.
  • Change in Inventory for Q4 2019 was $15000.0 at Plus Therapeutics, up from -$39000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $740000.0 in Q3 2015, with the low at -$630000.0 in Q2 2015.
  • Average Change in Inventory over 5 years is -$97300.0, with a median of -$120500.0 recorded in 2015.
  • The sharpest move saw Change in Inventory plummeted 2420.0% in 2015, then soared 306.0% in 2016.
  • Over 5 years, Change in Inventory stood at -$500000.0 in 2015, then soared by 43.8% to -$281000.0 in 2016, then soared by 173.31% to $206000.0 in 2017, then tumbled by 32.04% to $140000.0 in 2018, then tumbled by 89.29% to $15000.0 in 2019.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $15000.0, -$39000.0, and -$219000.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.